Pharma Equity Group A/S Stock

Pharma Equity Group A/S CROIC

The Cash Return on Invested Capital (CROIC) of Pharma Equity Group A/S (PEG.CO) as of Aug 22, 2026 is -138.67 %. In the previous year, Cash Return on Invested Capital (CROIC) was -46.77 % — a change of 196.47% (lower).

CROIC

-138.67 %

YoY

196.47%

Last updated:

Cash Return on Invested Capital (CROIC) of Pharma Equity Group A/S is 2026 -138.67 % . Cash Return on Invested Capital (CROIC) of Pharma Equity Group A/S was 2025 -46.77 % . It decreases by 196.47% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Pharma Equity Group A/S Stock analysis

What does Pharma Equity Group A/S do? Blue Vision A/S is a company specializing in the development, production, and marketing of underwater technology. It was founded in 1992 and is headquartered in Holstebro, Denmark. The company focuses on underwater lighting, underwater inspection cameras, and underwater communication. It specializes in manufacturing underwater lighting products for the offshore industry, ports, and shipping. It also produces underwater inspection cameras for inspecting underwater structures without the need for divers. In addition, the company has developed devices for underwater communication, which are crucial in the offshore industry and military sector. Blue Vision A/S emphasizes innovation and technology, holding patents and investing in digital technology to improve inspection systems. In summary, Blue Vision A/S specializes in underwater technology and offers solutions for the offshore industry, ports, and shipping. The company is committed to innovation and technology to provide the best solutions to its customers. Pharma Equity Group A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharma Equity Group A/S stock

Cash Return on Invested Capital (CROIC) of Pharma Equity Group A/S is -138.67 % in 2026.

Cash Return on Invested Capital (CROIC) of Pharma Equity Group A/S changed from -46.77 % to -138.67 %, representing a 196.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Pharma Equity Group A/S since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Pharma Equity Group A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Pharma Equity Group A/S

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Pharma Equity Group A/S